These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1672529)

  • 1. Immunoelectrophoretic characterizations of the cross-linking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. Identification of a rapid mode of hybrid alpha-/gamma-chain cross-linking that is promoted by the gamma-chain cross-linking.
    Shainoff JR; Urbanic DA; DiBello PM
    J Biol Chem; 1991 Apr; 266(10):6429-37. PubMed ID: 1672529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gly-Pro-Arg-Pro modifies the glutamine residues in the alpha- and gamma-chains of fibrinogen: inhibition of transglutaminase cross-linking.
    Achyuthan KE; Dobson JV; Greenberg CS
    Biochim Biophys Acta; 1986 Aug; 872(3):261-8. PubMed ID: 2873839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa.
    Samokhin GP; Lorand L
    J Biol Chem; 1995 Sep; 270(37):21827-32. PubMed ID: 7665605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive cross-linking of fibrin gamma chains increases resistance to fibrinolysis.
    Siebenlist KR; Mosesson MW
    J Biol Chem; 1994 Nov; 269(45):28414-9. PubMed ID: 7961782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard.
    Puszkin EG; Raghuraman V
    J Biol Chem; 1985 Dec; 260(29):16012-20. PubMed ID: 2866189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Position of gamma-chain carboxy-terminal regions in fibrinogen/fibrin cross-linking mixtures.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 2000 Nov; 39(46):14171-5. PubMed ID: 11087365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-Chain cross-linking in fibrin(ogen) Marburg.
    Sobel JH; Trakht I; Wu HQ; Rudchenko S; Egbring R
    Blood; 1995 Aug; 86(3):989-1000. PubMed ID: 7620190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-linked A alpha.gamma chain hybrids serve as unique markers for fibrinogen polymerized by tissue transglutaminase.
    Murthy SN; Lorand L
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9679-82. PubMed ID: 1979874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The covalent structure of factor XIIIa crosslinked fibrinogen fibrils.
    Mosesson MW; Siebenlist KR; Hainfeld JF; Wall JS
    J Struct Biol; 1995; 115(1):88-101. PubMed ID: 7577232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor XIIIa cross-links lipoprotein(a) with fibrinogen and is present in human atherosclerotic lesions.
    Romanic AM; Arleth AJ; Willette RN; Ohlstein EH
    Circ Res; 1998 Aug; 83(3):264-9. PubMed ID: 9710118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the alpha chain lysine donor sites involved in factor XIIIa fibrin cross-linking.
    Sobel JH; Gawinowicz MA
    J Biol Chem; 1996 Aug; 271(32):19288-97. PubMed ID: 8702612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed intermolecular gamma-chain cross-linking by factor XIIIa in fibrinogen Asahi characterized by a gamma-Met-310 to Thr substitution with an N-glycosylated gamma-Asn-308.
    Yamazumi K; Shimura K; Maekawa H; Muramatsu S; Terukina S; Matsuda M
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):557-9. PubMed ID: 1983463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicolour immuno-staining of fibrinogen polypeptide chains for identification of their derivatives in electrophoregrams.
    Shainoff JR; Urbanic DA
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):479-84. PubMed ID: 1723305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophoretic characterizations of cross-linked fibrinogen derivatives in blood and vascular tissue by zonal immobilization on glyoxyl agarose.
    Shainoff JR; Valenzuela R; Graor R; Urbanic DA; DiBello PM
    Adv Exp Med Biol; 1990; 281():73-81. PubMed ID: 2102627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen A alpha and gamma-chain dimers as potential differential indicators of atherosclerotic and thrombotic vascular disease.
    Shainoff JR; Valenzuela R; Urbanic DA; DiBello PM; Lucas FV; Graor R
    Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):499-503. PubMed ID: 1983461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-linking of plasminogen activator inhibitor 2 and alpha 2-antiplasmin to fibrin(ogen).
    Ritchie H; Lawrie LC; Crombie PW; Mosesson MW; Booth NA
    J Biol Chem; 2000 Aug; 275(32):24915-20. PubMed ID: 10816585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
    Kanaide H; Shainoff JR
    J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human inter-α-inhibitor is a substrate for factor XIIIa and tissue transglutaminase.
    Scavenius C; Sanggaard KW; Nikolajsen CL; Bak S; Valnickova Z; Thøgersen IB; Jensen ON; Højrup P; Enghild JJ
    Biochim Biophys Acta; 2011 Dec; 1814(12):1624-30. PubMed ID: 21939789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor XIIIa-derived peptides inhibit transglutaminase activity. Localization of substrate recognition sites.
    Achyuthan KE; Slaughter TF; Santiago MA; Enghild JJ; Greenberg CS
    J Biol Chem; 1993 Oct; 268(28):21284-92. PubMed ID: 8104938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas.
    Valenzuela R; Shainoff JR; DiBello PM; Urbanic DA; Anderson JM; Matsueda GR; Kudryk BJ
    Am J Pathol; 1992 Oct; 141(4):861-80. PubMed ID: 1415480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.